ZY

Zhi Yang

Managing Partner at BioVeda China Fund

China

Investor
VC

Invests in

Stages:

Series A
Seed

Sectors:

Wellness & Fitness
Pharmaceuticals
Consumer Health
Digital Health
BioTech
Health IT
Health & Hospital Services
FinTech

Locations:

Shanghai
  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

Due Diligence
Corporate Development
Drug Discovery
Mergers
Private Equity
Venture Capital
Business Strategy
Technology Transfer
Start-ups
Biotechnology
Corporate Finance
Lifesciences
Valuation
Mergers & Acquisitions
Financial Modeling
Pharmaceutical Industry

Education

  • HU

    PhD

    Harvard University

    (1984 - 1998)

  • HU

    Master of Arts (M.A.)

    Harvard University

    (1982 - 1984)

  • Master's degree

    Chinese Academy of Medical Sciences

    (1981 - 1982)

  • WU

    Bachelor of Science (BS)

    Wuhan University

    (1977 - 1981)

Lists including Zhi

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Cellenkos

Series A

Total Funding: $15M

Oculis

Series C

Total Funding: $190M

DiaCarta

Series A

Total Funding: $8M

CARsgen Therapeutics

Series A

Total Funding:

Jaguar Health

Series A

Total Funding: $7M

Work Experience

BioVeda China Fund

2005

  • Managing Partner

    2005

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.